FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SCA Pharmaceuticals ceFAZolin sodium added to 100 mL 0 Recall

ceFAZolin sodium added to 100 mL 0

SCA Pharmaceuticals · Little Rock, AR

Risk level
Class II
Reported by FDA
Jun 7, 2017
Recall ID
D-0877-2017
Check your lot numberHow we source this data

Summary

SCA Pharmaceuticals recalled ceFAZolin sodium added to 100 mL 0 starting May 18, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0877-2017 on Jun 7, 2017. Reason: Lack of assurance of sterility: Product bags leaking at seam. Status: Terminated.

Why it was recalled

Lack of assurance of sterility: Product bags leaking at seam.

Product description

ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 3g, Total Approximate Volume 115 mL, Single Dose Container bag, Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0524-32

Lot numbers, UPCs & expiration codes

LOT # 20170508@15, Use By: 06/22/17

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0877-2017
Classification
Class II
Status
Terminated
Recall initiated
May 18, 2017
FDA report date
Jun 7, 2017
Quantity
70 bags
Recall type
Voluntary: Firm initiated
Recalling firm
SCA Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-0877-2017, exactly as published.

Show all FDA fields
City
Little Rock
State
AR
Status
Terminated
Country
United States
Event ID
77314
Address
8821 Knoedl Ct
Code information
LOT # 20170508@15, Use By: 06/22/17
Postal code
72205-4600
Report date
Jun 7, 2017
Product type
Drugs
Recall number
D-0877-2017
Classification
Class II
Recalling firm
SCA Pharmaceuticals
Product quantity
70 bags
Termination date
Mar 29, 2018
Reason for recall
Lack of assurance of sterility: Product bags leaking at seam.
Voluntary / mandated
Voluntary: Firm initiated
Product description
ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 3g, Total Approximate Volume 115 mL, Single Dose Container bag, Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0524-32
Distribution pattern
Nationwide in the USA
Recall initiation date
May 18, 2017
Initial firm notification
Letter
Center classification date
May 31, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0877-2017, published Jun 7, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls